Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Drug Pricing

May 10, 2018 | Daily News

HHS' unexpected notification that the Health Resources and Services Administration planned to release wide-ranging “mega-guidance” on the 340B drug discount program was pulled from the 2018 spring unified agenda because it was mistakenly posted, a Health Resources and Services Administration spokesperson told Inside Health Policy.

May 10, 2018 | Daily News

Although brand drug makers are now lobbying to make plans share rebates with seniors at the point of sale, the drug industry in 2014 argued against any government interference in the business dealings among drug makers, plans and pharmacies, and sources say the drug industry has gotten away with changing its tune.

May 09, 2018 | Daily News

Brand drug lobbyists are worried the president’s plan to lower drug costs, which will be announced Friday, might include a measure to set prices at levels paid in other countries.

May 09, 2018 | Daily News

The spring 2018 unified agenda, released Wednesday (May 9), says that Health Resources and Services Administration is working on a final version of a wide-ranging “mega-guidance” on the 340B drug discount program that the administration had pulled shortly after coming into office.

May 08, 2018 | Daily News

President Donald Trump will announce his plan to reduce drug costs Friday (May 11) at the White House, a White House spokesperson said Tuesday.

May 08, 2018 | Daily News

The Vermont legislature has sent a bill to the governor’s desk directing the state to create a plan to safely import drugs from Canada.

May 08, 2018 | Daily News

Rep. Larry Bucshon (R-IN) is pushing the House Energy & Commerce Committee chair to hold a hearing on bills to reform the 340B hospital drug-discount program, but he doubts Congress will pass 340B legislation this year because opioid legislation will keep committee members busy for the next few months and it is an election year.

May 08, 2018 | Daily News

The Senate Aging Committee on Tuesday (May 8) held the first in a series of hearings on the rising price of insulin, and committee members seemed most interested in scrutinizing the transactions among drug makers, pharmacy benefit managers and health plans.

May 04, 2018 | Daily News

The Senate health committee plans to hold its second 340B hearing on May 15, according to an announcement released Friday (May 4), and the HHS Office of Inspector General and Government Accountability Office are set to testify.

May 04, 2018 | Daily News

A federal appeals court on Friday (May 4) heard oral arguments in the lawsuit brought by the American Hospital Association, America's Essential Hospitals, Association of American Medical Colleges and three hospitals over the cuts to Medicare Part B reimbursement for 340B drugs, and AHA says the court seemed most interested in whether Medicare law precludes judicial review of CMS' rule implementing the cuts.

May 04, 2018 | Daily News

The Congressional Budget Office underestimated by $4 billion government savings from a recent law that increased brand drug makers’ share of Part D donut-hole costs from 50 percent to 70 percent.

May 04, 2018 | Daily News

Baltimore health officials are urging the Trump administration to use a law, which was last considered by the Bush administration during the 2001 anthrax scare, to cut the price of the opioid-overdose drug naloxone.

May 04, 2018 | Daily News

The Health Resources and Services Administration proposed to again delay implementing the 340B ceiling price and penalty rule, and in the process revealed the Trump administration's highly anticipated plan to stem drug costs likely will affect four government health programs: 340B, Medicare Parts B and D, and Medicaid.

May 04, 2018 | Daily News

FDA Commissioner Scott Gottlieb caused confusion when he suggested Thursday (May 3) that the federal government reinterpret the treatment of drug rebates in anti-kickback regulations.

May 04, 2018 | Daily News

The Patent Trial and Appeal Board has quickly changed its policy on partially instituting inter partes patent reviews, following what some attorneys are calling a landmark ruling by the U.S. Supreme Court in SAS Institute v. Iancu that held the statute requires the board to act on all claims or none at all.

May 03, 2018 | Daily News

The Health Resources and Services Administration is requesting feedback on ways to simplify and reduce regulatory burdens for a number of programs under its jurisdiction, but the 340B drug discount program is not one of them.

May 03, 2018 | Daily News

HHS officials will brief congressional health staffers Friday (May 4) on drug prices, according to an HHS email to staff obtained by Inside Health Policy.

May 03, 2018 | Daily News

The government should reconsider the anti-kickback law’s treatment of drug rebates and make “a series of changes to the pricing mechanisms in Part D,” FDA Commissioner Scott Gottlieb said Thursday (May 3) in the context the president’s upcoming plan to lower drug costs for seniors.

May 03, 2018 | Daily News

The government should reconsider the anti-kickback law’s treatment of drug rebates and make “a series of changes to the pricing mechanisms in Part D,” FDA Commissioner Scott Gottlieb said Thursday (May 3) in the context the president’s upcoming plan to lower drug costs for seniors.

May 02, 2018 | Daily News

HHS Secretary Alex Azar said Wednesday (May 2) the president’s drug-cost plan will go further than his budget, but he didn’t say what those additional policies will be.

Pages